References of "Willems, Luc"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailLack of LTR and ENV genetic variation during bovine leukemia virus-induced leukemogenesis.
Willems, Luc ULg; Kerkhofs, P.; Burny, A. et al

in Virology (1995), 206(1),

Detailed reference viewed: 12 (5 ULg)
Full Text
Peer Reviewed
See detailRat embryo fibroblasts immortalization by bovine leukemia virus Tax protein
Willems, Luc ULg; Heremans, H.; Burny, A. et al

in Methods in Cell Science : An Official Journal of the Society for in Vitro Biology (1995)

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailNucleotide sequence of the ovine P53 tumor-suppressor cDNA and its genomic organization.
Dequiedt, Franck ULg; Kettmann, Richard ULg; Burny, A. et al

in DNA Sequence : The Journal of DNA Sequencing & Mapping (1995), 5(4),

Detailed reference viewed: 22 (7 ULg)
Full Text
Peer Reviewed
See detailNucleotide sequence of the bovine P53 tumor-suppressor cDNA.
Dequiedt, Franck ULg; Willems, Luc ULg; Burny, A. et al

in DNA Sequence : The Journal of DNA Sequencing & Mapping (1995), 5(4),

Detailed reference viewed: 31 (10 ULg)
Full Text
Peer Reviewed
See detailBovine Leukaemia Virus: biology and mode of transformation
Burny, A.; Willems, Luc ULg; Callebaut, I. et al

in Viruses and Cancer, Cambridge University Press (1994)

Detailed reference viewed: 30 (3 ULg)
Full Text
Peer Reviewed
See detailInvolvement Of The Cyclic Amp-Responsive Element-Binding Protein In Bovine Leukemia-Virus Expression In-Vivo
Adam, E.; Kerkhofs, P.; Mammerickx, M. et al

in Journal of Virology (1994), 68(9),

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailAttenuation Of Bovine Leukemia-Virus By Deletion Of R3 And G4 Open Reading Frames
Willems, Luc ULg; Kerkhofs, P.; Dequiedt, Franck ULg et al

in Proceedings of the National Academy of Sciences of the United States of America (1994), 91(24),

Detailed reference viewed: 10 (4 ULg)
Full Text
Peer Reviewed
See detailExpression Of Interleukin-6 Receptors And Interleukin-6 Messenger-Rna By Bovine Leukemia Virus-Induced Tumor-Cells
Droogmans, L.; Cludts, I.; Cleuter, Y. et al

in Cytokine (1994), 6(6),

Detailed reference viewed: 6 (2 ULg)
Full Text
Peer Reviewed
See detailBovine Leukemia Virus
Kettmann, Richard ULg; Burny, A.; Callebaut, I. et al

in The Retroviridae (1994)

Detailed reference viewed: 66 (19 ULg)
Full Text
Peer Reviewed
See detailIn vivo infection of sheep by bovine leukemia virus mutants.
Willems, Luc ULg; Kettmann, Richard ULg; Dequiedt, Franck ULg et al

in Journal of virology (1993), 67(7),

Detailed reference viewed: 7 (3 ULg)
Full Text
Peer Reviewed
See detailBovine leukemia virus, an animal model for the study of intrastrain variability.
Willems, Luc ULg; Thienpont, E.; Kerkhofs, P. et al

in Journal of Virology (1993), 67(2),

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailFusogenic Segments Of Bovine Leukemia-Virus And Simian Immunodeficiency Virus Are Interchangeable And Mediate Fusion By Means Of Oblique Insertion In The Lipid Bilayer Of Their Target-Cells
Voneche, V.; Portetelle, Daniel ULg; Kettmann, Richard ULg et al

in Proceedings of the National Academy of Sciences of the United States of America (1992), 89(9),

Modified bovine leukemia virus (BLV) glycoproteins were expressed by using vaccinia virus recombinants, and their fusogenic capacities were examined by a syncytia-formation assay. This analysis indicates ... [more ▼]

Modified bovine leukemia virus (BLV) glycoproteins were expressed by using vaccinia virus recombinants, and their fusogenic capacities were examined by a syncytia-formation assay. This analysis indicates that (i) both BLV envelope glycoproteins gp51 and gp30 are necessary for cell fusion; (ii) insertion of the N-terminal segment of gp30 (fusion peptide) into the lipid bilayer in an oblique orientation, as predicted by computer conformational analysis, results in fusogenic capacities higher than insertion in a perpendicular or parallel orientation; and (iii) replacement of the BLV fusion peptide with its simian immunodeficiency virus counterpart does not modify the fusogenic capacity of the BLV glycoprotein. [less ▲]

Detailed reference viewed: 60 (29 ULg)
Full Text
Peer Reviewed
See detailThe interaction between Bovine Leukemia Virus and its target cell.
Burny, Arsène; Kettmann, Richard ULg; Willems, Luc ULg et al

in AIDS Research and Human Retroviruses (1992), 8

Previous results indicate that the external glycoprotein gp51 of bovine leukemia virus plays an important role in the process of cell fusion induced by bovine leukemia virus (Bruck, C., Mathot, S ... [more ▼]

Previous results indicate that the external glycoprotein gp51 of bovine leukemia virus plays an important role in the process of cell fusion induced by bovine leukemia virus (Bruck, C., Mathot, S., Portetelle, D., Berte, C., Franssen, J. D., Herion, P., and Burny, A. (1982) Virology 122, 342-352; Voneche, V., Portetelle., D., Kettmann, R., Willems, L., Limbach, K., Paoletti, E., Ruysschaert, J. M., Burny, A., and Brasseur, R. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3810-3814) and suggest that a region encompassing residues 23 and 25 of gp51 is involved in this process (Portetelle, D., Couez, D., Bruck, C., Kettmann, R., Mammerickx, M., Van der Maaten, M., Brasseur, R., and Burny, A. (1989) Virology 169, 27-33; Mamoun, R., Morisson, M., Rebeyrotte, N., Busetta, B., Couez, D., Kettmann, R., Hospital, M., and Guillemain, B. (1990) J. Virol. 64, 4180-4188). X-ray diffraction studies performed on envelope glycoproteins of influenza virus indicate that the NH2-terminal part of the external glycoprotein lies very close to the fusion peptide. The same overall structure seems to exist in human immunodeficiency virus as suggested by site-directed mutagenesis followed by syncytia induction assays. Our theoretical studies indicate that a segment expanding between residues 19 and 27 of gp51 probably adopts an amphipathic beta-strand structure. We hypothesize that the amphipathic 19-27 structure of gp51 plays an important role in the process of membrane fusion by interacting with the fusion peptide or with another region of gp30. Mutational analysis disrupting the amphipathy of the 19-27 region strongly altered the fusogenic capacity of the gp51-gp30 complex. [less ▲]

Detailed reference viewed: 19 (4 ULg)
Full Text
Peer Reviewed
See detailMutations In The Bovine Leukemia-Virus Tax Protein Can Abrogate The Long Terminal Repeat-Directed Transactivating Activity Without Concomitant Loss Of Transforming Potential
Willems, Luc ULg; Grimonpont, C.; Heremans, H. et al

in Proceedings of the National Academy of Sciences of the United States of America (1992), 89(9),

Detailed reference viewed: 11 (4 ULg)
Full Text
Peer Reviewed
See detailIn vivo transfection of bovine leukemia provirus into sheep.
Willems, Luc ULg; Portetelle, Daniel ULg; Kerkhofs, P. et al

in Virology (1992), 189(2),

Detailed reference viewed: 10 (3 ULg)
Full Text
Peer Reviewed
See detailLeukemia Viruses
Burny, A.; Willems, Luc ULg

in Encyclopedia of Immunology (1991)

Detailed reference viewed: 9 (5 ULg)
Full Text
Peer Reviewed
See detailThe amino acid (157-197) peptide segment of bovine leukemia virus p34tax encompass a leucine-rich globally neutral activation domain.
Willems, Luc ULg; Kettmann, Richard ULg; Burny, A.

in Oncogene (1991), 6(1), 159-63

The specific DNA-binding Gal4 amino-terminal portion (amino acids 1 to 147) was fused to protein segments of BLV transactivator p34tax and tested for its capacity to activate CAT-gene expression in ... [more ▼]

The specific DNA-binding Gal4 amino-terminal portion (amino acids 1 to 147) was fused to protein segments of BLV transactivator p34tax and tested for its capacity to activate CAT-gene expression in mammalian cells. The p34tax peptide segment 157 to 197 encompasses an activating region. The segment is approximately located in the middle of p34tax and is globally neutral (net charge zero). The tax (157-197) domain contains 24% of leucine residues, possibly involved in heterologous protein interactions. [less ▲]

Detailed reference viewed: 15 (0 ULg)